Robert Chess sold $250K of Twist Bioscience (TWST)

Executed Jan 7 2025, disclosed Jan 10 2025, 3 days later, against a two-business-day limit.

Value, as filed

$250K

5,000 sh × $50.00

Executed

Jan 7 2025

the trade date, as filed

Disclosed

Jan 10 2025

3 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Robert Chess Director profile →

Robert Chess (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Twist Bioscience Corporation (TWST). The largest single filing was $2.0M of TWST (18,417 sh × $110.89, as filed), executed Aug 7.

The name

TWST

Twist Bioscience Corporation TWST · Healthcare · 102 filings in 24 months ticker →

Healthcare · Twist Bioscience Corporation manufactures and sells synthetic DNA-based products

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Robert Chess in TWST

TWSTSALE Twist Bioscience Corporation $2.0M
18,417 sh × $110.89
Exec Aug 7
Filed Aug 11 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $470K
10,000 sh × $47.00
Exec Mar 17
Filed Mar 19 · 5:30 PM ET TWSTSALE Twist Bioscience Corporation $105K
2,184 sh × $48.26
Exec Feb 13
Filed Feb 18 · 5:30 PM ET TWSTSALE Twist Bioscience Corporation $156K
2,940 sh × $53.14
Exec Feb 7 2025
Filed Feb 11 2025 · 5:30 PM ET TWSTSALE Twist Bioscience Corporation $145K
2,795 sh × $51.70
Exec Dec 5 2024
Filed Dec 30 2024 · 5:30 PM ET † TWSTSALE Twist Bioscience Corporation $109K
2,324 sh × $46.99
Exec Nov 11 2024
Filed Nov 13 2024 · 5:30 PM ET